美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA209401"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
68727-745-01 68727-745 HUMAN PRESCRIPTION DRUG VYXEOS (daunorubicin and cytarabine) liposome INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION INTRAVENOUS 20170803 N/A NDA NDA209401 Jazz Pharmaceuticals, Inc. CYTARABINE; DAUNORUBICIN 100 mg/20mL; 44 mg/20mL 20 mL in 1 VIAL (68727-745-01)
68727-745-02 68727-745 HUMAN PRESCRIPTION DRUG VYXEOS (daunorubicin and cytarabine) liposome INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION INTRAVENOUS 20170803 N/A NDA NDA209401 Jazz Pharmaceuticals, Inc. CYTARABINE; DAUNORUBICIN 100 mg/20mL; 44 mg/20mL 40 mL in 1 CARTON (68727-745-02)
68727-745-05 68727-745 HUMAN PRESCRIPTION DRUG VYXEOS (daunorubicin and cytarabine) liposome INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION INTRAVENOUS 20170803 N/A NDA NDA209401 Jazz Pharmaceuticals, Inc. CYTARABINE; DAUNORUBICIN 100 mg/20mL; 44 mg/20mL 100 mL in 1 CARTON (68727-745-05)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase